InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,723.20
(
0.00%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
82.99
(
-0.27%
)
Bitcoin
61,823.99
(
-1.72%
)
Post# of 3834
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Darwinian

Send PM Follow Ignore
Followers 9
Posts 540
Boards Moderated 0
Alias Born 01/26/2014

Darwinian

Re: None

Thursday, 04/07/2016 12:23:20 AM

Thursday, April 07, 2016 12:23:20 AM

Post# of 3834
I don't post on other boards much but noticed that someone asked about GR-MD-02 being inravenous and the impact of that on it's marketability. Kinda silly to think that someone would choose to allow their fibrosis to worsen to the point of cirrhosis because of the intravenous delivery. I agree oral treatment would be the preferred method.

This old pr came to mind when I saw the post on the other board today.

http://investor.galectintherapeutics.com/releasedetail.cfm?releaseid=855926

If the intravenous drug is approved, would the oral delivery drug likely have a quick, easy pathway to delivery?

People on that other board don't seem to dig very deep when researching a company and it's pipeline...
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent GALT News
More GALT News
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!